Biotech Values

[DewDiligence]

The MON-DOW deal corroborates my thesis in #msg-86643556—i.e. MON has already become more aggressive in business development now that they have been freed from the antitrust straightjacket.

Of course, the timing of today’s MON-DOW deal could just be a coincidence, but it might not be :- )